Stay updated on Durvalumab Combo in Advanced Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedA new publication citation for the HIMALAYA five-year survival update was added, and the page revision tag updated from v3.5.3 to v3.5.4.SummaryDifference0.0%

- Check28 days agoChange DetectedThe Taiwan recruitment locations were updated: Taoyuan District, Taiwan was removed and Taoyuan, Taiwan was added.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page’s displayed site/version label has been updated from Revision v3.5.2 to Revision v3.5.3, indicating a minor update to the ClinicalTrials.gov site itself rather than any change to the study record.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check71 days agoChange DetectedAdded Naples, Italy as a location and removed Napoli, Italy from the study locations.SummaryDifference0.1%

- Check78 days agoChange DetectedAdded Hepatocellular carcinoma keyword and Genetic and Rare Diseases Information Center resource. Updated site revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combo in Advanced Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page.